Division of Insurance Medicine
Sickness absence affects individuals, health care, insurance organizations, employers, and society. Nevertheless, the scientific knowledge base is very limited. We conduct research, systematic literature reviews, post graduate training, and networking regarding sickness absence, work disability, health, and living conditions.
Heidi Taipale has been granted 7 million SEK from Sigrid Juselius stifelse in Finland for her research project which addresses real-world effectiveness of complex pharmacotherapy regimens and their dose-response relationships for schizophrenia and possibilities to enhance it with genetic data.
Kristin Farrants and Alexis Cullen have been granted 3.0 million and 2.4 million respectively from The Swedish Research Council. Kristin Farrants received the grant for her project on morbidity among older women and men in paid work and Alexis Cullen for her project on early detection and intervention strategies regarding psychosis.
Katalin Gémes has been granted 4.4 million SEK
Katalin Gémes has been granted 4.4 million SEK from FORTE for her research project The role of multimorbidity, social factors, work environment and treatment on labor market marginalization after sick leave due to depression, anxiety and stress-related mental disorders.
Iman Alaie has been granted 2 million SEK
Iman Alaie has been granted 2 million SEK from Forte for his project: Childhood-onset neuropsychiatric conditions and the risk of labor market marginalization in adulthood: Focusing on etiologic mechanisms and putative developmental pathways
Chantelle Murley has defended her doctoral thesis
Chantelle Murley has successfully defended her thesis entitled Work disability, economic situation, and societal costs of multiple sclerosis in Sweden.
Ridwan Amin has defended his thesis
Ridwanul Amin has defended his thesis entitled Suicidal behaviour and healthcare use among refugees.
Kristin Farrants har been granted 5.6 million
Kristin Farrants has been granted 5.6 million from Forte to study gender differences in working situation and sickness absence after the age of 65.
Emilie Friberg has been granted 3,2 million
Emilie Friberg has been granted 3,2 million from the AFA Insurance in order to study health and work ability among pedestrians of working age who were injured in a fall accident in a road environment or in a collision with another road user.
Kristin Farrants has been granted 3.8 million from AFA
Kristin Farrants has been granted 3.8 million from AFA Insurance to study sickness absence and disability pension among blue-collar workers in the trade industry during the Covid-19 pandemic.
Professor Kristina Alexanderson awarded the 2020 Silver Medal
Kristina Alexanderson, Professor of Social Insurance at the Department of Clinical Neuroscience is awarded the medal for her excellent contribution to the development of social insurance research and competence at KI. She has placed KI firmly on the map as a leading university in the field, nationally as well as internationally.
KI researchers in EU-funded COVID-19 projects
Researchers at Karolinska Institutet are taking part in three projects funded as part of the EU’s second major investment in research on COVID-19 and the pandemic. The total research grant for KI amounts to just over SEK 14 million. Ellenor Mittendorfer-Rutz is the leader of the RESPOND study at KI.
New report on psychosocial work environment
Per Lytsy and Emilie Friberg have compiled a new report that contains two systematic literature reviews on the existing research on the factors which create healthy and vital workplaces.
Jurgita Narusyte has been granted 4.9 million SEK
Jurgita Narusyte has been granted 4.9 million SEK from AFA Insurance in order to investigate how depression, anxiety and ADHD in young people relate to sickness absence later in life.
Magnus Helgesson has been granted 4.9 million SEK
Magnus Helgesson has been granted 4.9 million SEK from AFA Insurance in order to investigate if drug- and psychotherapy can increase the potential for employees with common mental disorders to continue working despite their illness, and which psychosocial and organizational workplace factors can prevent sickness absence among people with these diagnoses.
New licentiate thesis
Linnea Kjeldgård has defended her licentiate thesis entitled Sickness absence and disability pension among individuals injured in a bicycle crash.
New doctoral thesis
Mirkka Söderman has defended her thesis entitled Healthcare professionals’ work with sickness absence : with focus on oncology.
New doctoral thesis
Rasmus Elrud has defended his thesis entitled Sickness absence, disability pension, and permanent medical impairment among car occupants injured in a crash.
People with cluster headache have twice as many sick-leave days as those without
In a new Swedish study, published in the medical journal Neurology, it was found that people with cluster headache have twice as many sick-leave days as people without. The researchers also found that women with cluster headache had twice as many sick-leave days as men with the same disease. That an episodic disease has some effect on working life was expected, but not that the differences were that large.
New study shows that long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal World Psychiatry, mortality was higher during periods when patients were not on medication than when they were.
New grant to the Division of Insurance Medicine
Jurgita Narusyte has been granted 4.9 million SEK from AFA Insurance within the research program “Living and working with mental ill-health”. The overall purpose of the funded project is to investigate the associations between mental ill-health and sickness absence among individuals employed in the private sector.
Ellenor Mittendorfer-Rutz was inaugurated as a professor
Ellenor Mittendorfer-Rutz was inaugurated as KI´s first professor in Insurance Medicine during a ceremony held in Aula Medica.
"We represent many disciplines within medical science, but we are united in the aim of improving people’s health,” said Ellenor Mittendorfer-Rutz in her professor’s speech.
Kristin Farrants has been granted 1.8 milllion SEK
Kristin Farrants has been granted 1.8 million SEK from Handelsrådet for a project regarding sickness absence and disability pension among white-collar workers in trade. The project will consist of cohort studies with a 5-year follow-up based on linked register data.
Annina Ropponen has been granted 4.7 million SEK
Annina Ropponen has been granted 4.7 million SEK from Forte for a research project regarding the associations between early life factors and sustainable working life using twin design.
Emilie Friberg has been granted 5 million SEK
Emilie Friberg has been granted 5 million SEK for a project about multiple sclerosis (MS), gainful employment and sick leave from Försäkringskassan.
The project is expected to generate important knowledge that is often requested by doctors and patients about strategies for being able to work as long as possible.
Karolinska Institutet has now a professor in Insurance Medicine!
Ellenor Mittendorfer-Rutz has begun her position as a Professor of Insurance Medicine at the Division of Insurance Medicine, the Department of Clinical Neuroscience at Karolinska Institutet in April this year. The research area of insurance medicine is relatively new, however, it has developed much during the last years. Karolinska Institutet has taken a leading role in this development both nationally and internationally – a role that will be even more pronounced now.
New study found no evidence of increase in risk of suicide
This new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic and finds that suicide numbers largely remained unchanged in the pandemic’s early months. However, the authors stress that governments must remain vigilant as the longer-term mental health and economic effects of the pandemic unfold and be poised to respond if the situation changes. The study included around 70 authors from 30 countries who are members of the International COVID-19 Suicide Prevention Research Collaboration (ICSPRC).
Celebrating 5 years!
The field of Cochrane Insurance Medicine (CIM) was created by researchers from Switzerland, the Netherlands, Sweden and Canada for five years ago. Since then research in this field had increased in number of countries stimulated by the recognition of insurance medicine (IM) as a specialty with particular broad research needs. The aim of CIM is to make IM more evidence-based, promoting the production and use of scientific evidence to support IM practice. CIM has also become a platform for IM researchers and professionals to connect and collaborate.
Click here to read an article
Cochrane Insurance Medicine
Cochrane Insurance Medicine (CIM) has been established as a field within Cochrane.
CIM aims to establish and make evidence based knowledge regarding insurance medicine available for professionals and users.
The Division of Insurance Medicine has, together with groups from three other countries, worked since many years to establish this as a field within Cochrane.
Agreement on the new European Data Protection Legislation good for research
The European parliament, the Council of Ministers, and the European Commission have agreed on a common text which will replace national legislations on data protection by 2018 (PUL in Sweden).